Valsesia-Wittmann S - Search Results

1

Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells.

Valsesia-Wittmann S, Magdeleine M, Dupasquier S, Garin E, Jallas AC, Combaret V, Krause A, Leissner P, Puisieux A. Valsesia-Wittmann S, et al. Cancer Cell. 2004 Dec;6(6):625-30. doi: 10.1016/j.ccr.2004.09.033. Cancer Cell. 2004. PMID: 15607966 Free article.

2

BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells.

el-Ghissassi F, Valsesia-Wittmann S, Falette N, Duriez C, Walden PD, Puisieux A. el-Ghissassi F, et al. Oncogene. 2002 Oct 3;21(44):6772-78. doi: 10.1038/sj.onc.1205888. Oncogene. 2002. PMID: 12360398

3

Genome-wide analysis of gene expression in neuroblastomas detected by mass screening.

Krause A, Combaret V, Iacono I, Lacroix B, Compagnon C, Bergeron C, Valsesia-Wittmann S, Leissner P, Mougin B, Puisieux A. Krause A, et al. Cancer Lett. 2005 Jul 8;225(1):111-20. doi: 10.1016/j.canlet.2004.10.035. Epub 2004 Dec 8. Cancer Lett. 2005. PMID: 15922863 Free article.

4

A twist for survival and cancer progression.

Puisieux A, Valsesia-Wittmann S, Ansieau S. Puisieux A, et al. Br J Cancer. 2006 Jan 16;94(1):13-7. doi: 10.1038/sj.bjc.6602876. Br J Cancer. 2006. PMID: 16306876 Free PMC article. Review.

5

[Cancer cells escape from failsafe programs in a simple Twist].

Puisieux A, Valsesia-Wittmann S. Puisieux A, et al. Bull Cancer. 2006 Mar 1;93(3):251-6. Bull Cancer. 2006. PMID: 16567311 Free article. Review. French.

6

Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence.

Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S, Maestro R, Voeltzel T, Selmi A, Valsesia-Wittmann S, Caron de Fromentel C, Puisieux A. Ansieau S, et al. Cancer Cell. 2008 Jul 8;14(1):79-89. doi: 10.1016/j.ccr.2008.06.005. Cancer Cell. 2008. PMID: 18598946 Free article.

7

Cancer stem cells: the emerging challenge of drug targeting.

Besançon R, Valsesia-Wittmann S, Puisieux A, Caron de Fromentel C, Maguer-Satta V. Besançon R, et al. Curr Med Chem. 2009;16(4):394-416. doi: 10.2174/092986709787315531. Curr Med Chem. 2009. PMID: 19199913 Review.

8

Upstream ORF affects MYCN translation depending on exon 1b alternative splicing.

Besançon R, Valsesia-Wittmann S, Locher C, Delloye-Bourgeois C, Furhman L, Tutrone G, Bertrand C, Jallas AC, Garin E, Puisieux A. Besançon R, et al. BMC Cancer. 2009 Dec 17;9:445. doi: 10.1186/1471-2407-9-445. BMC Cancer. 2009. PMID: 20017904 Free PMC article.

9

Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells.

Kogan-Sakin I, Tabach Y, Buganim Y, Molchadsky A, Solomon H, Madar S, Kamer I, Stambolsky P, Shelly A, Goldfinger N, Valsesia-Wittmann S, Puisieux A, Zundelevich A, Gal-Yam EN, Avivi C, Barshack I, Brait M, Sidransky D, Domany E, Rotter V. Kogan-Sakin I, et al. Cell Death Differ. 2011 Feb;18(2):271-81. doi: 10.1038/cdd.2010.94. Epub 2010 Aug 6. Cell Death Differ. 2011. PMID: 20689556 Free PMC article.

10

TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma.

Selmi A, de Saint-Jean M, Jallas AC, Garin E, Hogarty MD, Bénard J, Puisieux A, Marabelle A, Valsesia-Wittmann S. Selmi A, et al. Cancer Lett. 2015 Feb 1;357(1):412-418. doi: 10.1016/j.canlet.2014.11.056. Epub 2014 Dec 1. Cancer Lett. 2015. PMID: 25475555

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters